COMPANY

VeriSIM Life, Inc.

HQ: San Francisco, CA source · verisimlife.com ↗ · West Coast

Keywords: oncology machine learning artificial intelligence

Location: San Francisco, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $513K (STTR Phase II 5R42DA056084-03, continuation, notice Aug 14, 2026). NIH RePORTER 5R42DA056084-03 (Aug 14, 2026)
Evidence (1 event)
- Aug 14, 2026 · NIH RePORTER 5R42DA056084-03
  Organization: VERISIM LIFE, INC.; City/State: SAN FRANCISCO, CA; Project number: 5R42DA056084-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-14; FY total cost (award amount): 512644; Administering IC: National Institute on Drug Abuse; Project title: Development of therapeutic candidates for stimulant use disorder using AI-driven platform for focused drug discovery and accelerated development; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 14, 2026 Grant Government grant — STTR: $512,644 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NIDA. Source: government award database. source ↗
Jul 16, 2025 Grant Government grant — STTR: $811,876 (annual award, as published), announced Jul 16, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

Last 2 years.

Aug 14, 2026 Government grant — STTR: $512,644 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NIDA. Source: government award database. source ↗
Jul 16, 2025 Government grant — STTR: $811,876 (annual award, as published), announced Jul 16, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

Annual award amounts. Total $312K.

Mar 17, 2022 NIH award 1R43DA056084-01 FY2022: $312,310 awarded for that fiscal year; activity R43 (SBIR); PI VARSHNEY, JYOTIKA; recipient as written: VERISIM LIFE, INC., SAN FRANCISCO, CA. Development of the AI-driven model for source ↗